Mass Spectrometry-Based Comparative Analysis of N -Glycosylation Alterations in Three Human Body Fluids in Parkinson’s Disease
ACS Chemical Neuroscience · 2025
DOI: 10.1021/acschemneuro.5c00654 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift ACS Chemical Neuroscience, 2025. Verfasst von Lingbo Zhao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Clinical Mass Spectrometry, School of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu 215123, China. Hauptthemen laut MEDLINE: Parkinson Disease, Glycoproteins, Body Fluids. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Priority Academic Program Development of Jiangsu Higher Education Institutions, Shantou University Medical College, Neurological Disease Research Centre of the Second Hospital of Soochow University.
Abstract (Originalsprache)
Parkinson's disease (PD) is a progressive neurodegenerative disorder lacking definitive diagnostic tests. To identify new diagnostic biomarkers, we employed glycoproteomics-mass spectrometry (MS) to investigate dynamic changes in protein N-glycosylation across the serum, urine, and saliva of PD patients. Our comparative analysis of differentially expressed glycoproteins (DEGs) between PD patients and healthy controls (HCs) revealed distinct patterns. Specifically, ATPase phospholipid transporter 11B (ATP11B) was significantly upregulated in the serum of PD patients, while urine and saliva showed an opposite trend. Other key findings included elevated myeloperoxidase (MPO) in urine and clusterin (CLU) in serum. Zinc-α-2-glycoprotein (AZGP1), detected in all three biofluids, displayed increased sialylation and core fucosylation in serum but decreased levels in the saliva and urine of PD patients, along with a distinct bifucosylation pattern in saliva. These glycoprotein expression changes were further validated using enzyme-linked immunoassay (ELISA). Pathway analysis indicated that these DEGs are primarily involved in inflammatory response, complement activation, and synaptic plasticity, suggesting that glycosylation dysregulation may contribute to PD progression by modulating neuroinflammation and protein homeostasis. This study represents the first comprehensive analysis of multibiofluid N-glycosylation in PD. The findings offer potential biomarkers and provide insights into the molecular mechanisms of the disease, which could ultimately inform early diagnosis and the development of targeted therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Clinical Mass Spectrometry, School of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu 215123, China.
- Department of Respiratory Medicine, The Fourth Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215123, China.
- Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown UniversityMedical Center, Georgetown University, Washington, District of Columbia 20057, United States.
- Department of Neurology and Clinical Research Center of Neurological Disease, The Second Affiliated Hospital of Soochow University, Suzhou 215004, China.
- Nanjing Apollomics Biotech, Inc., Nanjing, Jiangsu 210033, China.
- Laboratory of Clinical and Molecular Glycobiology, Institute of Glycomics, Shantou University Medical College, Shantou, Guangdong 515041, China.
ORCID-Profile: Chunyan Hou, Chun-Feng Liu, Junfeng Ma, Shuang Yang
Förderung
- Priority Academic Program Development of Jiangsu Higher Education Institutions
- Shantou University Medical College
- Neurological Disease Research Centre of the Second Hospital of Soochow University
- Jiangsu Shuangchuang Boshi Funding
- Suzhou Medical Innovation Funding
- Jiangsu Science and Technology Plan Funding
- Suzhou Science and Technology
Zitieren
APA
Zhao, L., Hou, C., Gao, Y., Jin, H., Liu, C. F., Li, S., Ma, J., & Yang, S. (2025). Mass Spectrometry-Based Comparative Analysis of N -Glycosylation Alterations in Three Human Body Fluids in Parkinson’s Disease. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.5c00654
Vancouver
Zhao L, Hou C, Gao Y, Jin H, Liu CF, Li S, et al. Mass Spectrometry-Based Comparative Analysis of N -Glycosylation Alterations in Three Human Body Fluids in Parkinson’s Disease. ACS Chemical Neuroscience. 2025. doi:10.1021/acschemneuro.5c00654
BibTeX
@article{Zhao2025,
author = {Zhao, Lingbo and Hou, Chunyan and Gao, Yu and Jin, Hong and Liu, Chun-Feng and Li, Shuwei and Ma, Junfeng and Yang, Shuang},
title = {Mass Spectrometry-Based Comparative Analysis of N -Glycosylation Alterations in Three Human Body Fluids in Parkinson’s Disease},
journal = {ACS Chemical Neuroscience},
year = {2025},
doi = {10.1021/acschemneuro.5c00654}
}
EUVIMED